Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 201–300 of 1,035
Sun, L., Pang, Y., Wang, X., Wu, Q., Liu, H., Liu, B., Liu, G., Ye, M., Kong, W., & Jiang, C. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.004 · Cited by 204
Teixeira, T. F. S., Souza, N. C. S., Chiarello, P. G., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., & Peluzio, M. D. C. G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.009 · Cited by 201
Bauer, F., Elbers, C. C., Adan, R. A., Loos, R. J., Onland-Moret, N. C., Grobbee, D. E., van Vliet-Ostaptchouk, J. V., Wijmenga, C., & van der Schouw, Y. T. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27781 · Cited by 205
“Because visceral fat accumulation in particular is related to health risk, we chose to use waist circumference as a measure specific for the amount of intraabdominal (visceral) fat, because this might be a more specific measure of obesity than a general adiposity measure, such as BMI (24, 25).”
BackgroundBody fat distribution and the risk of incident metabolic syndrome: A longitudinal cohort study
Kwon, H., Kim, D., & Kim, J. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09723-y · Cited by 205
Effects of Bariatric Surgery on Cardiac Ectopic Fat
Gaborit, B., Jacquier, A., Kober, F., Abdesselam, I., Cuisset, T., Boullu-Ciocca, S., Emungania, O., Alessi, M.-C., Clément, K., Bernard, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.016 · Cited by 205
“Accumulation of ectopic fat, including visceral obesity, has been recognized recently to be a consequence of adipose tissue (AT) dysfunction and the inability of subcutaneous AT to store excess triglycerides with weight gain (1,2).”
BackgroundExcess body fat in obese and normal-weight subjects
Thomas, E. L., Frost, G., Taylor-Robinson, S. D., & Bell, J. D. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000054 · Cited by 196
“Després & Lemieux(105) proposed that excess visceral fat deposition could be a marker of ‘dysfunctional’ adipose tissue, which in turn is associated with increased ectopic fat deposition in the liver, heart, skeletal muscle and pancreas.”
BackgroundInfluentialWaist Circumference Measurement in Clinical Practice
Ness‐Abramof, R., & Apovian, C. M. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608321700 · Cited by 192
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High‐fat Diet
Starowicz, K. M., Cristino, L., Matias, I., Capasso, R., Racioppi, A., Izzo, A. A., & Di Marzo, V. (2008) · Obesity · doi:10.1038/oby.2007.106 · Cited by 194
“13, for review), might explain the recent positive association found between 2-AG levels and intra-abdominal adiposity as well as other cardiovascular risk factors, such as low adiponectin levels, hyperglycemia, and glucose intolerance (28,29), whose occurrence seems to depend particularly on the presence and amounts…”
BackgroundIntermuscular adipose tissue in metabolic disease
Goodpaster, B. H., Bergman, B. C., Brennan, A. M., & Sparks, L. M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00784-2 · Cited by 177
Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology?
Lemieux, I., Poirier, P., Bergeron, J., Alméras, N., Lamarche, B., Cantin, B., Dagenais, G. R., & Després, J.-P. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)71007-3 · Cited by 200
Self-citationLee, J. J., Pedley, A., Hoffmann, U., Massaro, J. M., & Fox, C. S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.067 · Cited by 198
“Simultaneously, the adipose tissue remodeling process accompanies dysfunctional modification in the fat properties, such as abnormal excretion of anti- and proinflammatory adipokines (31,32), alteration in free fatty acid metabolism (33), poor vascularity (34), and cellular hypoxia (35).”
Born, J. M., Lemmens, S. G. T., Rutters, F., Nieuwenhuizen, A. G., Formisano, E., Goebel, R., & Westerterp-Plantenga, M. S. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.221 · Cited by 191
Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome
Carobbio, S., Pellegrinelli, V., & Vidal-Puig, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_7 · Cited by 194
Patil, N., Jérôme, C., & Detrembleur, C. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.04.002 · Cited by 199
Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
Kiefer, F. W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M. D., Geyeregger, R., Schlederer, M., Kenner, L., et al. (2010) · Diabetes · doi:10.2337/db09-0404 · Cited by 200
“Diabetes 59:935–946, 2010 Obesity is a major risk factor for the development of insulin resistance, which is a fundamental step toward type 2 diabetes and cardiovascular disease (1).”
BackgroundChen, Y.-K., Cheung, C., Reuhl, K. R., Liu, A. B., Lee, M.-J., Lu, Y.-P., & Yang, C. S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2029016 · Cited by 195
“Obesity plays an important role in promoting the development of metabolic diseases, which includes hyperinsulinemia, hypertension, hyperlipidemia, type 2 diabetes mellitus, and an increased risk of atherosclerotic cardiovascular disease (1, 2).”
BackgroundDesprés, J.-P., Ross, R., Boka, G., Alméras, N., & Lemieux, I. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.176362 · Cited by 200
“Adipose tissue areas (cm(2)) were computed using an attenuation range of –190 to –30 Hounsfield units (HU) as previously described.(6) Of the 231”
MethodSelf-citationVan Gaal, L., Pi-Sunyer, X., Després, J.-P., McCarthy, C., & Scheen, A. (2008) · Diabetes Care · doi:10.2337/dc08-s258 · Cited by 199
“CONCLUSIONS — Global cardiometabolic risk represents the overall risk of developing type 2 diabetes and/or cardiovascular disease due to a cluster of modifiable risk factors/markers (1).”
BackgroundSelf-citationVitamin D and adipose tissue—more than storage
Mutt, S. J., Hyppönen, E., Saarnio, J., Järvelin, M.-R., & Herzig, K.-H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00228 · Cited by 189
“Excess in adipose tissue has been attributed to a variety of diseases including cancer, diabetes, cardiovascular and neurodegenerative diseases and decrease in life expectancy (Adams et al., 2006; Despres and Lemieux, 2006; Kahn et al., 2006; Van Gaal et al., 2006).”
BackgroundCatalán, V., Gómez-Ambrosi, J., Rodríguez, A., Ramírez, B., Silva, C., Rotellar, F., Gil, M. J., Cienfuegos, J. A., Salvador, J., & Frühbeck, G. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0486-8 · Cited by 193
“A large body of evidence shows that visceral obesity is associated with a higher risk of obesity-related comorbidities whereas subcutaneous fat deposition has been associated with a decreased risk of cardiovascular diseases [36, 37].”
Nicklas, B. J., Wang, X., You, T., Lyles, M. F., Demons, J., Easter, L., Berry, M. J., Lenchik, L., & Carr, J. J. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26938 · Cited by 193
“This excess adipose tissue in the abdomen, especially around visceral organs, increases metabolic risk of cardiovascular disease (CVD) independent of the total amount of adipose tissue (4, 5).”
BackgroundKlaver, M., de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., Dekker, M. J. H. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0496 · Cited by 198
SPARC: a key player in the pathologies associated with obesity and diabetes
Kos, K., & Wilding, J. P. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.18 · Cited by 192
“This finding supports the concept that subcutaneous adipose tissue acts as a 'metabolic sink'”
ResultAdipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170042 · Cited by 164
Kang, S. M., Yoon, J. W., Ahn, H. Y., Kim, S. Y., Lee, K. H., Shin, H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027694 · Cited by 197
“There is substantial evidence providing that fat distribution is a better predictor of cardiovascular disease than the degree of obesity [1–5].”
BackgroundLeiter, L. A., Fitchett, D. H., Gilbert, R. E., Gupta, M., Mancini, G. B. J., McFarlane, P. A., Ross, R., Teoh, H., Verma, S., Anand, S., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.054 · Cited by 186
Self-citationGoldbacher, E. M., & Matthews, K. A. (2007) · Annals of Behavioral Medicine · doi:10.1007/bf02874549 · Cited by 196
Clemente, M. G., Mandato, C., Poeta, M., & Vajro, P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8078 · Cited by 188
Metabolically healthy obesity across the life course: epidemiology, determinants, and implications
Phillips, C. M. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13230 · Cited by 189
Gualillo, O., González-Juanatey, J. R., & Lago, F. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.005 · Cited by 193
Tzanetakou, I. P., Katsilambros, N. L., Benetos, A., Mikhailidis, D. P., & Perrea, D. N. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.003 · Cited by 184
de Souza, R. J., Bray, G. A., Carey, V. J., Hall, K. D., LeBoff, M. S., Loria, C. M., Laranjo, N. M., Sacks, F. M., & Smith, S. R. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.026328 · Cited by 192
Hutchison, S. K., Stepto, N. K., Harrison, C. L., Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0828 · Cited by 192
Inflammatory cause of metabolic syndrome via brain stress and NF-κB
Cai, D., & Liu, T. (2012) · Aging · doi:10.18632/aging.100431 · Cited by 189
“blood pressure, which are collectively called metabolic syndrome [13-19].”
BackgroundThe Renal Pathology of Obesity
Tsuboi, N., Okabayashi, Y., Shimizu, A., & Yokoo, T. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.01.007 · Cited by 174
“Deposition of Lipid Components Accumulation of fat components in cells, originally a vital function for conserving intracellular energy, is increased in obesity.(55) Numerous experiments in vivo and in vitro have suggested an association between intrarenal accumulation of lipid components and renal injury.”
BackgroundForkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure
Nakae, J., Cao, Y., Oki, M., Orba, Y., Sawa, H., Kiyonari, H., Iskandar, K., Suga, K., Lombes, M., & Hayashi, Y. (2008) · Diabetes · doi:10.2337/db07-0698 · Cited by 187
“” This means that energy storage will be partitioned toward the visceral fat depot and subsequently into ectopic fat depots, which include intrahepatocellular and intramyocellular lipids, both of which will have direct negative effects on insulin action in these tissues (1,6).”
BackgroundAn atlas of DNA methylomes in porcine adipose and muscle tissues
Li, M., Wu, H., Luo, Z., Xia, Y., Guan, J., Wang, T., Gu, Y., Chen, L., Zhang, K., Ma, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1854 · Cited by 189
“, PAD, which is located between visceral and parietal pericardium); and (4) IAD, the adipose visible between muscle groups and beneath the muscle fascia in the hips.”
BackgroundInfluentialRelevance of body composition in phenotyping the obesities
Salmón-Gómez, L., Catalán, V., Frühbeck, G., & Gómez-Ambrosi, J. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09796-3 · Cited by 158
Arsenault, B. J., Lemieux, I., Despres, J.-P., Wareham, N. J., Kastelein, J. J. P., Khaw, K.-T., & Boekholdt, S. M. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091276 · Cited by 182
“Hypertriglyceridemia combined with an increased waistline could be a marker of lipid overflow resulting from a relative defect of adipose tissue to clear and store the excess triglycerides from overnutrition and lack of physical activity.(1) We believe that the hypertriglyceridemic-waist phenotype should not replace t…”
BackgroundSelf-citationBody Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
Kim, D., Chung, G. E., Kwak, M.-S., Seo, H. B., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Lee, H.-S., & Kim, C. Y. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.024 · Cited by 174
Turcotte, A.-F., O’Connor, S., Morin, S. N., Gibbs, J. C., Willie, B. M., Jean, S., & Gagnon, C. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252487 · Cited by 166
Peterson, M. D., Gordon, P. M., & Hurvitz, E. A. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01052.x · Cited by 176
“Left untreated, this combination of pathophysiological factors precipitates increased risk for cardiometabolic disease and early all-cause mortality across populations (33,34).”
BackgroundStrength Exercise Improves Muscle Mass and Hepatic Insulin Sensitivity in Obese Youth
VAN DER HEIJDEN, G.-J., WANG, Z. J., CHU, Z., TOFFOLO, G., MANESSO, E., SAUER, P. J. J., & SUNEHAG, A. L. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181df16d9 · Cited by 177
“Copyright @ 2010 to defective fat storage in this compartment with subsequent overflow of fat into visceral, hepatic, and intramyocellular fat deposits (9,38).”
Feng, X., Weng, D., Zhou, F., Owen, Y. D., Qin, H., Zhao, J., WenYu, Huang, Y., Chen, J., Fu, H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.017 · Cited by 176
“Obesity causes excess fat accumulation and chronic low-grade inflammation in various tissues, especially in insulin-responsive organs such as skeletal muscle, liver and adipose tissue, thereby contributing to the development of metabolic abnormalities (Despres and Lemieux, 2006).”
BackgroundChan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 177
“Central-obesity is the most prevalent manifestation of MetS and reflective of dysfunctional adipose tissue which favours the development of insulin resistance (Despres & Lemieux, 2006) .”
BackgroundEffects of Catechin Enriched Green Tea on Body Composition
Wang, H., Wen, Y., Du, Y., Yan, X., Guo, H., Rycroft, J. A., Boon, N., Kovacs, E. M. R., & Mela, D. J. (2010) · Obesity · doi:10.1038/oby.2009.256 · Cited by 185
“This raises the possibility that a very high-catechin GT could have a disproportionate effect on reducing fat mass in visceral and abdominal adipose depots, fat storage sites which may be particularly associated with metabolic disease risk (14).”
BackgroundCoherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis
Le, T. T., Huff, T. B., & Cheng, J.-X. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-42 · Cited by 184
“Visceral adipose tissues are generally accepted as endocrine organs which regulate body lipid and energy homeostasis [22,23].”
BackgroundGut Microbiota, Low-grade Inflammation, and Metabolic Syndrome
Chassaing, B., & Gewirtz, A. T. (2014) · Toxicologic Pathology · doi:10.1177/0192623313508481 · Cited by 172
“While obesity is the most recognizable aspect of metabolic syndrome, the central feature of this disorder is insulin resistance (Despres and Lemieux 2006).”
BackgroundMohan, M., Al-Talabany, S., McKinnie, A., Mordi, I. R., Singh, J. S. S., Gandy, S. J., Baig, F., Hussain, M. S., Bhalraam, U., Khan, F., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz203 · Cited by 170
“Other than BP, insulin resistance (IR) and central obesity are implicated in the development of LVH. Dysglycaemia is very common in patients with CAD and is linked to IR.9 Large studies have reported a significant positive relationship between IR and LVH.10–12 Specifically, central obesity has been associated with IR,…”
BackgroundInfluentialNonalcoholic fatty liver disease and polycystic ovary syndrome
Vassilatou, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8351 · Cited by 173
Neprilysin, obesity and the metabolic syndrome
Standeven, K. F., Hess, K., Carter, A. M., Rice, G. I., Cordell, P. A., Balmforth, A. J., Lu, B., Scott, D. J., Turner, A. J., Hooper, N. M., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.227 · Cited by 174
Marinou, K., Hodson, L., Vasan, S. K., Fielding, B. A., Banerjee, R., Brismar, K., Koutsilieris, M., Clark, A., Neville, M. J., & Karpe, F. (2014) · Diabetes Care · doi:10.2337/dc13-1353 · Cited by 176
“The classical abdominal adipose tissue (AT) compartmentalization into subcutaneous (SAT) and visceral AT (VAT) has been widely studied in relation to obesity related complications (2-4).”
BackgroundNazare, J.-A., Smith, J., Borel, A.-L., Aschner, P., Barter, P., Van Gaal, L., Tan, C. E., Wittchen, H.-U., Matsuzawa, Y., Kadowaki, T., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.10.039 · Cited by 175
“This finding further supports the hypothesis that the increased CVD risk is partially because of excess VAT and liver fat,(17,23) contributing to insulin resistance, atherosclerosis, and inflammation.(3) Our findings are in line with studies that have reported that the association with CVD risk factors (triglycerides,…”
ResultSelf-citationvan der Voort, Gaillard, R., Hofman, A., de Jongste, J. C., & Duijts, L. (2013) · Cited by 181
Understanding androgen action in adipose tissue
O’Reilly, M. W., House, P. J., & Tomlinson., J. W. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.008 · Cited by 180
Metabolic impact of estrogen signalling through ERalpha and ERbeta
Foryst-Ludwig, A., & Kintscher, U. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.06.012 · Cited by 178
Visceral obesity and the heart
Mathieu, P., Pibarot, P., Larose, É., Poirier, P., Marette, A., & Després, J.-P. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.001 · Cited by 174
Self-citationMediterranean Dietary Patterns and Cardiovascular Health
Shen, J., Wilmot, K. A., Ghasemzadeh, N., Molloy, D. L., Burkman, G., Mekonnen, G., Gongora, M. C., Quyyumi, A. A., & Sperling, L. S. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-011215-025104 · Cited by 172
Zhang, D., Liu, X., Liu, Y., Sun, X., Wang, B., Ren, Y., Zhao, Y., Zhou, J., Han, C., Yin, L., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.001 · Cited by 166
“PA may decrease the risk of MetS by reducing abdominal obesity [46, 47].”
BackgroundCoffee consumption, obesity and type 2 diabetes: a mini-review
Santos, R. M. M., & Lima, D. R. A. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1206-0 · Cited by 169
“1 3 undesirable sites such as the liver, the heart and the skeletal muscle as a visceral adipose tissue, known as fat ectopic deposition [3, 15].”
Goldszmid, R. S., & Trinchieri, G. (2012) · Nature Immunology · doi:10.1038/ni.2422 · Cited by 166
The Metabolically Benign and Malignant Fatty Liver
Stefan, N., & Häring, H.-U. (2011) · Diabetes · doi:10.2337/db11-0231 · Cited by 169
Insulin resistance and body composition in cancer patients
Dev, R., Bruera, E., & Dalal, S. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx815 · Cited by 165
The FoxO transcription factors and metabolic regulation
Nakae, J., Oki, M., & Cao, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.025 · Cited by 176
“sclerosis [88].”
Ectopic fat and cardiometabolic and vascular risk
Lim, S., & Meigs, J. B. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.077 · Cited by 173
“Several mechanisms have been proposed to explain the relationship betweenVAT and cardiometabolic and vascular risk [2,45].”
BackgroundPrevalence of polycystic ovary syndrome in adolescents
Christensen, S. B., Black, M. H., Smith, N., Martinez, M. M., Jacobsen, S. J., Porter, A. H., & Koebnick, C. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.001 · Cited by 169
“Abdominal visceral adipose tissue has been identified as a better marker of metabolic health than body weight (30) and mouse models of PCOS suggest that adipose tissue and tissue-specific inflammation play a crucial role in the development of PCOS (31).”
BackgroundTsatsoulis, A., Mantzaris, M. D., Bellou, S., & Andrikoula, M. (2013) · Metabolism · doi:10.1016/j.metabol.2012.11.004 · Cited by 174
“It is also believed that central obesity and associated resistance to the metabolic actions of insulin lie at the root of the problem [8,9].”
BackgroundMahabadi, A. A., Reinsch, N., Lehmann, N., Altenbernd, J., Kälsch, H., Seibel, R. M., Erbel, R., & Möhlenkamp, S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.013 · Cited by 169
“Visceral adipose tissue of the abdomen is an established risk actor for cardiovascular disease [1] and is associated with cariovascular and metabolic risk factors [2].”
BackgroundAmbient Fine Particulate Matter, Outdoor Temperature, and Risk of Metabolic Syndrome
Wallwork, R. S., Colicino, E., Zhong, J., Kloog, I., Coull, B. A., Vokonas, P., Schwartz, J. D., & Baccarelli, A. A. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww157 · Cited by 176
“5 nor temperature was significantly associated with abdominal obesity, low HDL cholesterol, or hypertension, all of which are key components of metabolic syndrome that are often presented as underlying and/or preceding the other components (40) and cardiovascular morbidity (41, 42).”
BackgroundVendrell, J., El Bekay, R., Peral, B., García-Fuentes, E., Megia, A., Macias-Gonzalez, M., Real, J. F., Jimenez-Gomez, Y., Escoté, X., Pachón, G., et al. (2011) · Endocrinology · doi:10.1210/en.2011-1070 · Cited by 173
Improved weight management using genetic information to personalize a calorie controlled diet
Arkadianos, I., Valdes, A. M., Marinos, E., Florou, A., Gill, R. D., & Grimaldi, K. A. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-29 · Cited by 165
“The weight loss recorded in the nutrigenetically tested group after one year was moderate, and it has been well established that even a small weight loss coupled with a healthier diet and lifestyle can lead to significant reduction in risks for diseases associated with excess weight such as diabetes, CVD and metabolic…”
The Role of Dietary Nutrients in Inflammatory Bowel Disease
Sugihara, K., Morhardt, T. L., & Kamada, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03183 · Cited by 166
Ryan, S. (2017) · The Journal of Physiology · doi:10.1113/jp273312 · Cited by 159
“Furthermore, the distribution of excess adipose tissue has significant impact on pathophysiological consequences, wherein increased visceral fat mass to a greater extent than subcutaneous adipose tissue is associated with serious health consequences (Despres & Lemieux, 2006).”
BackgroundYamakado, M., Nagao, K., Imaizumi, A., Tani, M., Toda, A., Tanaka, T., Jinzu, H., Miyano, H., Yamamoto, H., Daimon, T., et al. (2015) · Scientific Reports · doi:10.1038/srep11918 · Cited by 169
Tsushita, K., Hosler, A. S., Miura, K., Ito, Y., Fukuda, T., Kitamura, A., & Tatara, K. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.42010 · Cited by 178
Barrea, L., Pugliese, G., Frías-Toral, E., Ghoch, M. E., Castellucci, B., Chapela, S. P., Carignano, M. D. L. A., Laudisio, D., Savastano, S., Colao, A., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1963207 · Cited by 190
“…represents a critical cardiovascular risk factor, up to including waist circumference, as a simple and accurate predictor of abdominal obesity in the diagnostic criteria of the MetS (Alberti et al., 2009; Alberti, Zimmet, and Shaw 2006; Despres and Lemieux 2006; Grundy et al. 2005; Stefan 2020).”
BackgroundEarnest, C. P., Artero, E. G., Sui, X., Lee, D.-C., Church, T. S., & Blair, S. N. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.11.006 · Cited by 170
The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes
Ou, H.-Y., Wang, C.-Y., Yang, Y.-C., Chen, M.-F., & Chang, C.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062561 · Cited by 166
“, ectopic fat deposition) such as the liver, skeletal muscle, heart, and even in the pancreas [2–3].”
BackgroundObesity and post‐operative complications in patients undergoing non‐bariatric surgery
Doyle, S. L., Lysaght, J., & Reynolds, J. V. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00700.x · Cited by 163
“An additional consequence of adipose tissue excess, specifically an excess of intraabdominal, or visceral adipose tissue is the metabolic syndrome where there is a prothrombotic, pro-inflammatory state associated with insulin resistance (5).”
BackgroundInfluentialMelgar, B., Dias, M. I., Ciric, A., Sokovic, M., Garcia-Castello, E. M., Rodriguez-Lopez, A. D., Barros, L., & Ferreira, I. C. R. F. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2017.10.024 · Cited by 161
Redox changes in obesity, metabolic syndrome, and diabetes
Korac, B., Kalezic, A., Pekovic-Vaughan, V., Korac, A., & Jankovic, A. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101887 · Cited by 158
“Hyperinsulinemia represents a risk factor for cardiovascular disease, neurodegeneration, diabetes, and cancer [112], while this type of dysfunction is a commonly observed feature in several animal models”
BackgroundElffers, T. W., de Mutsert, R., Lamb, H. J., de Roos, A., Willems van Dijk, K., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185403 · Cited by 167
Kiefer, F. W., Zeyda, M., Todoric, J., Huber, J., Geyeregger, R., Weichhart, T., Aszmann, O., Ludvik, B., Silberhumer, G. R., Prager, G., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1312 · Cited by 161
Sumner, A. E. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.04.049 · Cited by 165
Relation Between Body Mass Index, Waist Circumference, and Death After Acute Myocardial Infarction
Zeller, M., Steg, P. G., Ravisy, J., Lorgis, L., Laurent, Y., Sicard, P., Janin-Manificat, L., Beer, J.-C., Makki, H., Lagrost, A.-C., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.753483 · Cited by 159
Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance
Kakimoto, P. A., & Kowaltowski, A. J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.01.009 · Cited by 159
“It is widely accepted that mitochondrial oxidative imbalance contributes toward the development and progression of NAFLD and related metabolic diseases ([61,6]).”
BackgroundInfluentialDempsey, P. C., Owen, N., Yates, T. E., Kingwell, B. A., & Dunstan, D. W. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0797-4 · Cited by 161
Shao, M., Vishvanath, L., Busbuso, N. C., Hepler, C., Shan, B., Sharma, A. X., Chen, S., Yu, X., An, Y. A., Zhu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03196-x · Cited by 161
Filippi, S., Vignozzi, L., Morelli, A., Chavalmane, A. K., Sarchielli, E., Fibbi, B., Saad, F., Sandner, P., Ruggiano, P., Vannelli, G. B., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01467.x · Cited by 166
Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy
Le, T. T., Yue, S., & Cheng, J.-X. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r008730 · Cited by 166
Sigit, F. S., Tahapary, D. L., Trompet, S., Sartono, E., van Dijk, K. W., Rosendaal, F. R., & de Mutsert, R. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0503-1 · Cited by 193
Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots
Agrawal, S., Wang, M., Klarqvist, M. D. R., Smith, K., Shin, J., Dashti, H., Diamant, N., Choi, S. H., Jurgens, S. J., Ellinor, P. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30931-2 · Cited by 156
Wang, C., Wang, C., Huang, H., & Wei, Y. (2013) · The FEBS Journal · doi:10.1111/febs.12096 · Cited by 165
Watanabe, K., Wilmanski, T., Diener, C., Earls, J. C., Zimmer, A., Lincoln, B., Hadlock, J. J., Lovejoy, J. C., Gibbons, S. M., Magis, A. T., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02248-0 · Cited by 143
Anty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V. J., Senni‐Buratti, M., Ben Amor, I., Staccini‐Myx, A., Saint‐Paul, M. ‐., Berthier, F., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04480.x · Cited by 153
Prakash, O., Hossain, F. M., Danos, D., Lassak, A., Scribner, R. A., & Miele, L. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.576964 · Cited by 180
Ong, W. K., Tan, C. S., Chan, K. L., Goesantoso, G. G., Chan, X. H. D., Chan, E., Yin, J., Yeo, C. R., Khoo, C. M., So, J. B. Y., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.01.002 · Cited by 162
“Accumulation of fat in the VS depot, on the other hand, leads to pathological metabolic profile because of dysfunction in lipid storage (Després and Lemieux, 2006).”
BackgroundHypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 159
Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota
Mishra, A. K., Dubey, V., & Ghosh, A. R. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.008 · Cited by 161
Adiponectin as a routine clinical biomarker
Kishida, K., Funahashi, T., & Shimomura, I. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.08.006 · Cited by 170
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.